EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension

Yoshiaki Furuya, Toru Satoh, Masataka Kuwana

International Journal of Rheumatology · 2010 · 2010 · 1-8

DOI: 10.1155/2010/720305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatology, 2010. Verfasst von Yoshiaki Furuya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi,Shinjuku-ku, Tokyo 160-8582, Japan. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Ministry of Health, Labour and Welfare.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-6 (IL-6) is a pleiotropic cytokine with a wide range of biologic activities in immune regulation, hematopoiesis, inflammation, and oncogenesis. Recent accumulating evidence indicates a pathologic role for IL-6 in promoting proliferation of both smooth muscle and endothelial cells in the pulmonary arterioles, resulting in development of pulmonary arterial hypertension (PAH). Here, we describe a patient with mixed connective tissue disease and severe, refractory PAH. Her functional activity and hemodynamic parameters dramatically responded to tocilizumab, a humanized monoclonal antibody to human IL-6 receptor, which was aimed at treating multicentric Castleman's disease. It appears that IL-6 blockade may hold promise as an adjunct drug in treatment of PAH in idiopathic form as well as in association with connective tissue disease.

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi,Shinjuku-ku, Tokyo 160-8582, Japan.

Förderung

  • Ministry of Health, Labour and Welfare

Zitieren

APA

Furuya, Y., Satoh, T., & Kuwana, M. (2010). Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension. International Journal of Rheumatology, 2010, 1-8. https://doi.org/10.1155/2010/720305

Vancouver

Furuya Y, Satoh T, Kuwana M. Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension. International Journal of Rheumatology. 2010;2010:1-8. doi:10.1155/2010/720305

BibTeX
@article{Furuya2010,
  author = {Furuya, Yoshiaki and Satoh, Toru and Kuwana, Masataka},
  title = {Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension},
  journal = {International Journal of Rheumatology},
  year = {2010},
  volume = {2010},
  pages = {1--8},
  doi = {10.1155/2010/720305}
}
Kostenlos starten →